1. Home
  2. ITRM vs ARAI Comparison

ITRM vs ARAI Comparison

Compare ITRM & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

ARAI

Arrive AI Inc.

HOLD

Current Price

$0.49

Market Cap

25.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
ARAI
Founded
2015
2020
Country
Ireland
United States
Employees
N/A
51
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
25.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ITRM
ARAI
Price
$0.03
$0.49
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.00
$12.00
AVG Volume (30 Days)
30.9M
1.2M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$800.66
Revenue Next Year
$947.65
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.40
52 Week High
$1.13
$12.85

Technical Indicators

Market Signals
Indicator
ITRM
ARAI
Relative Strength Index (RSI) 26.10 39.77
Support Level N/A $0.40
Resistance Level $0.39 $0.78
Average True Range (ATR) 0.02 0.07
MACD -0.01 -0.00
Stochastic Oscillator 3.34 38.42

Price Performance

Historical Comparison
ITRM
ARAI

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: